Invesco
IMVT icon

Invesco’s Immunovant IMVT Stock Holding History

Invesco’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64M Buy
94,351
+457
+0.5% +$13.9K ﹤0.01% 2348
2026
Q1 		$2.33M Buy
93,894
+5,037
+6% +$130K ﹤0.01% 2476
2025
Q4 		$2.26M Buy
88,857
+12,255
+16% +$273K ﹤0.01% 2568
2025
Q3 		$1.23M Buy
76,602
+9,852
+15% +$159K ﹤0.01% 2834
2025
Q2 		$1.07M Buy
66,750
+11,438
+21% +$173K ﹤0.01% 2818
2025
Q1 		$945K Sell
55,312
-448,720
-89% -$9.39M ﹤0.01% 2855
2024
Q4 		$12.5M Sell
504,032
-90,210
-15% -$2.56M ﹤0.01% 1721
2024
Q3 		$16.9M Buy
594,242
+23,344
+4% +$688K ﹤0.01% 1552
2024
Q2 		$15.1M Buy
570,898
+44,665
+8% +$1.27M ﹤0.01% 1570
2024
Q1 		$17M Buy
526,233
+34,118
+7% +$1.24M ﹤0.01% 1530
2023
Q4 		$20.7M Buy
492,115
+253,060
+106% +$9.31M ﹤0.01% 1387
2023
Q3 		$9.18M Buy
239,055
+216,455
+958% +$4.89M ﹤0.01% 1819
2023
Q2 		$429K Buy
22,600
+6,563
+41% +$122K ﹤0.01% 3324
2023
Q1 		$249K Sell
16,037
-825
-5% -$14.3K ﹤0.01% 3556
2022
Q4 		$299K Buy
16,862
+828
+5% +$10.4K ﹤0.01% 3508
2022
Q3 		$89K Sell
16,034
-209
-1% -$1.02K ﹤0.01% 3856
2022
Q2 		$63K Sell
16,243
-2,457
-13% -$10.6K ﹤0.01% 3947
2022
Q1 		$103K Buy
18,700
+711
+4% +$4.43K ﹤0.01% 3865
2021
Q4 		$153K Sell
17,989
-2,935
-14% -$24.2K ﹤0.01% 3838
2021
Q3 		$182K Sell
20,924
-841,089
-98% -$7.59M ﹤0.01% 3834
2021
Q2 		$9.11M Buy
862,013
+2,151
+0.3% +$30K ﹤0.01% 2107
2021
Q1 		$13.8M Sell
859,862
-267,625
-24% -$7.06M ﹤0.01% 1764
2020
Q4 		$52.1M Buy
1,127,487
+882,862
+361% +$40.8M 0.02% 1007
2020
Q3 		$8.61M Buy
244,625
+94,776
+63% +$2.85M ﹤0.01% 1727
2020
Q2 		$3.65M Buy
+149,849
New +$3.21M ﹤0.01% 2169

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's IMVT Position: Q2 2026 in Review

Invesco increased its Immunovant (IMVT) stake by 0.49% in Q2 2026, buying an estimated $13.9K and bringing the position to 94,351 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

Invesco first reported a position in IMVT in Q2 2020 and has held it in 25 quarters since. The position peaked at $52.1M in Q4 2020. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Invesco held 94,351 shares of Immunovant worth $3.64M as of Q2 2026.
  • Invesco bought 457 Immunovant shares in Q2 2026, an estimated $13.9K.
  • Immunovant made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2348 holding.
  • Invesco first reported a position in Immunovant in Q2 2020 and has held it in 25 quarters since.
  • Invesco's Immunovant position peaked at $52.1M in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.